Fonar Corporation
FONAR Corporation, together with its subsidiaries, engages in the designing, manufacturing, selling, and servicing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries in the United States. It operates in two segments: Medical Equipment, and Physician Management and Diagnostic Services. The company of… Read more
Market Cap & Net Worth: Fonar Corporation (FONR)
Fonar Corporation (NASDAQ:FONR) has a market capitalization of $113.63 Million ($113.63 Million) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #18541 globally and #6897 in its home market, demonstrating a -0.38% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Fonar Corporation's stock price $18.42 by its total outstanding shares 6168625 (6.17 Million).
Fonar Corporation Market Cap History: 2015 to 2026
Fonar Corporation's market capitalization history from 2015 to 2026. Data shows growth from $106.47 Million to $113.63 Million (0.52% CAGR).
Index Memberships
Fonar Corporation is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.00% | #506 of 976 |
|
NASDAQ Composite
IXIC
|
$33.26 Trillion | 0.00% | #1704 of 3165 |
Weight: Fonar Corporation's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Fonar Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Fonar Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.10x
Fonar Corporation's market cap is 1.10 times its annual revenue
0.68x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
13.74x
Fonar Corporation's market cap is 13.74 times its annual earnings
359.02x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $118.13 Million | $73.37 Million | $15.72 Million | 1.61x | 7.51x |
| 2017 | $150.21 Million | $78.04 Million | $19.62 Million | 1.92x | 7.66x |
| 2018 | $124.85 Million | $81.52 Million | $21.23 Million | 1.53x | 5.88x |
| 2019 | $121.46 Million | $87.19 Million | $15.32 Million | 1.39x | 7.93x |
| 2020 | $107.09 Million | $85.69 Million | $8.24 Million | 1.25x | 13.00x |
| 2021 | $89.94 Million | $89.93 Million | $10.21 Million | 1.00x | 8.81x |
| 2022 | $103.32 Million | $97.59 Million | $12.44 Million | 1.06x | 8.31x |
| 2023 | $120.66 Million | $98.65 Million | $9.38 Million | 1.22x | 12.87x |
| 2024 | $93.39 Million | $102.88 Million | $10.57 Million | 0.91x | 8.84x |
| 2025 | $114.49 Million | $104.35 Million | $8.33 Million | 1.10x | 13.74x |
Competitor Companies of FONR by Market Capitalization
Companies near Fonar Corporation in the global market cap rankings as of March 18, 2026.
Key companies related to Fonar Corporation by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #91 globally with a market cap of $176.18 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #154 globally with a market cap of $120.38 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.34 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #512 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #91 | Thermo Fisher Scientific Inc | NYSE:TMO | $176.18 Billion | $470.00 |
| #154 | Danaher Corporation | NYSE:DHR | $120.38 Billion | $191.39 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.34 Billion | $586.37 |
| #512 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Fonar Corporation Historical Marketcap From 2015 to 2026
Between 2015 and today, Fonar Corporation's market cap moved from $106.47 Million to $ 113.63 Million, with a yearly change of 0.52%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $113.63 Million | -0.75% |
| 2025 | $114.49 Million | +22.59% |
| 2024 | $93.39 Million | -22.60% |
| 2023 | $120.66 Million | +16.78% |
| 2022 | $103.32 Million | +14.88% |
| 2021 | $89.94 Million | -16.01% |
| 2020 | $107.09 Million | -11.83% |
| 2019 | $121.46 Million | -2.72% |
| 2018 | $124.85 Million | -16.88% |
| 2017 | $150.21 Million | +27.15% |
| 2016 | $118.13 Million | +10.95% |
| 2015 | $106.47 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Fonar Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $113.63 Million USD |
| MoneyControl | $113.63 Million USD |
| MarketWatch | $113.63 Million USD |
| marketcap.company | $113.63 Million USD |
| Reuters | $113.63 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.